Muriel Noetzli

453 total citations
7 papers, 358 citations indexed

About

Muriel Noetzli is a scholar working on Organic Chemistry, Pediatrics, Perinatology and Child Health and Psychiatry and Mental health. According to data from OpenAlex, Muriel Noetzli has authored 7 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Organic Chemistry, 3 papers in Pediatrics, Perinatology and Child Health and 3 papers in Psychiatry and Mental health. Recurrent topics in Muriel Noetzli's work include Epilepsy research and treatment (3 papers), Pharmacological Effects and Toxicity Studies (3 papers) and Cholinesterase and Neurodegenerative Diseases (2 papers). Muriel Noetzli is often cited by papers focused on Epilepsy research and treatment (3 papers), Pharmacological Effects and Toxicity Studies (3 papers) and Cholinesterase and Neurodegenerative Diseases (2 papers). Muriel Noetzli collaborates with scholars based in Switzerland and United States. Muriel Noetzli's co-authors include Chin B. Eap, Nicolas Ansermot, Maria Dobrinas, Eva Choong, Pantéleimon Giannakopoulos, Chantal Csajka, Armin von Gunten, Monia Guidi, Jacques Cornuz and Agnès Michon and has published in prestigious journals such as Clinical Pharmacokinetics, British Journal of Clinical Pharmacology and Journal of Pharmaceutical and Biomedical Analysis.

In The Last Decade

Muriel Noetzli

7 papers receiving 336 citations

Peers

Countries citing papers authored by Muriel Noetzli

Since Specialization

Citations

This map shows the geographic impact of Muriel Noetzli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muriel Noetzli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muriel Noetzli more than expected).

Fields of papers citing papers by Muriel Noetzli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Muriel Noetzli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muriel Noetzli. The network helps show where Muriel Noetzli may publish in the future.

Co-authorship network of co-authors of Muriel Noetzli

This figure shows the co-authorship network connecting the top 25 collaborators of Muriel Noetzli. A scholar is included among the top collaborators of Muriel Noetzli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Muriel Noetzli. Muriel Noetzli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

#	Work	Indexed citations
1	Population pharmacokinetic approach to evaluate the effect of CYP2D6, CYP3A, ABCB1, POR and NR1I2 genotypes on donepezil clearance 2014 ·British Journal of Clinical Pharmacology ·Muriel Noetzli, Monia Guidi, (unknown), (unknown), (unknown), Agnès Michon, (unknown), (unknown), (unknown), Christophe Büla, (unknown), M.L. Gaillard, Pantéleimon Giannakopoulos, Armin von Gunten, Chantal Csajka, Chin B. Eap	45
2	Population Pharmacokinetic Study of Memantine: Effects of Clinical and Genetic Factors 2013 ·Clinical Pharmacokinetics ·Muriel Noetzli, Monia Guidi, (unknown), (unknown), (unknown), Agnès Michon, (unknown), (unknown), (unknown), (unknown), Pantéleimon Giannakopoulos, Armin von Gunten, Chantal Csajka, Chin B. Eap	31
3	Pharmacodynamic, Pharmacokinetic and Pharmacogenetic Aspects of Drugs Used in the Treatment of Alzheimer’s Disease 2013 ·Clinical Pharmacokinetics ·Muriel Noetzli, Chin B. Eap	152
4	Relationship of CYP2D6, CYP3A, POR, and ABCB1 Genotypes With Galantamine Plasma Concentrations 2013 ·Therapeutic Drug Monitoring ·Muriel Noetzli, Monia Guidi, (unknown), (unknown), (unknown), Pantéleimon Giannakopoulos, Armin von Gunten, Chantal Csajka, Chin B. Eap	21
5	Simultaneous determination of antidementia drugs in human plasma: Procedure transfer from HPLC–MS to UPLC–MS/MS 2012 ·Journal of Pharmaceutical and Biomedical Analysis ·Muriel Noetzli, Nicolas Ansermot, Maria Dobrinas, Chin B. Eap	48
6	Quantification of nicotine, cotinine, trans-3′-hydroxycotinine and varenicline in human plasma by a sensitive and specific UPLC–tandem mass-spectrometry procedure for a clinical study on smoking cessation 2011 ·Journal of Chromatography B ·Maria Dobrinas, Eva Choong, Muriel Noetzli, Jacques Cornuz, Nicolas Ansermot, Chin B. Eap	37
7	Simultaneous Determination of Antidementia Drugs in Human Plasma for Therapeutic Drug Monitoring 2011 ·Therapeutic Drug Monitoring ·Muriel Noetzli, Eva Choong, Nicolas Ansermot, Chin B. Eap	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact